Location History:
- Scottsdale, AZ (US) (2014)
- Pickering, CA (2015)
Company Filing History:
Years Active: 2014-2015
Title: David Watt: Innovator in Acne Treatment Solutions
Introduction
David Watt is an accomplished inventor based in Pickering, Canada, recognized for his significant contributions to the field of dermatological treatments, particularly for acne. With two patents to his name, he has made strides in developing effective oral dosage forms utilizing minocycline.
Latest Patents
David Watt's latest patents include innovative methods for the treatment of acne through specific oral dosage forms. One of these patents details an oral dosage form containing 65 mg of minocycline, lactose monohydrate, and hydroxypropylmethylcellulose, characterized by an 8.9% hydroxypropoxylation. Another patent covers oral dosage forms with varying minocycline amounts—55 mg, 80 mg, and 105 mg—that achieve a specific dissolution profile essential for effective treatment. The method not only aims to treat acne but also assists physicians in determining appropriate dosages of minocycline.
Career Highlights
David Watt currently works at Medicis Pharmaceutical Corporation, a company known for its commitment to developing innovative solutions for dermatological needs. His work focuses on formulating and advancing treatments that target common skin conditions, positioning him as a key player in the pharmaceutical industry.
Collaborations
Throughout his career, David has collaborated with several industry professionals, including notable colleagues Mitchell S. Wortzman and R. Todd Plott. These partnerships enhance the research and development of effective medications, facilitating progress within the company and contributing to their mission of improving skin health.
Conclusion
David Watt's contributions to the field of acne treatment through his patents highlight his dedication to improving patient care. His innovative approaches to formulating minocycline dosage forms showcase the pivotal role inventors play in advancing medical treatments. Through his work at Medicis Pharmaceutical Corporation and collaborations with esteemed colleagues, he continues to influence the landscape of dermatological solutions.